Template:Atrial fibrillation: Difference between revisions
Jump to navigation
Jump to search
Esther Lee (talk | contribs) No edit summary |
No edit summary |
||
(37 intermediate revisions by 12 users not shown) | |||
Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: | {| class="infobox bordered" style="width: 15%; text-align: left; font-size: 85%; background:AliceBlue" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:DarkGray" | | | colspan="1" style="text-align:center; background:DarkGray" | | ||
'''Atrial Fibrillation Microchapters''' | |||
'''Atrial | |||
''' | |||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
! | ! | ||
Line 28: | Line 26: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation historical perspective|Historical Perspective]] | ||
|- | |- | ||
! | ! | ||
Line 40: | Line 38: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation pathophysiology|Pathophysiology]] | ||
|- | |||
! | |||
|- bgcolor="Pink" | |||
! | |||
[[Atrial fibrillation causes|Causes]] | |||
|- | |- | ||
! | ! | ||
Line 46: | Line 50: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation differential diagnosis|Differentiating Atrial Fibrillation from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 52: | Line 56: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 58: | Line 62: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 64: | Line 68: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 70: | Line 74: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 84: | Line 88: | ||
: [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | : [[Atrial fibrillation pulmonary diseases|Pulmonary Diseases]] | ||
: [[Atrial fibrillation pregnancy|Pregnancy]] | : [[Atrial fibrillation pregnancy|Pregnancy]] | ||
: [[Atrial fibrillation medical therapy in patients presenting with ACS and/or PCI or valve intervention|ACS and/or PCI or valve intervention]] | |||
: [[Congestive heart failure treatment of patients who have concomitant disorders|Heart failure]] | |||
|- | |- | ||
! | ! | ||
Line 89: | Line 95: | ||
|- bgcolor="CornFlowerBlue" | |- bgcolor="CornFlowerBlue" | ||
! | ! | ||
Diagnosis | |||
|- | |- | ||
! | ! | ||
Line 107: | Line 113: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Atrial fibrillation laboratory | [[Atrial fibrillation laboratory findings|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 114: | Line 120: | ||
! | ! | ||
[[Atrial fibrillation electrocardiogram|Electrocardiogram]] | [[Atrial fibrillation electrocardiogram|Electrocardiogram]] | ||
:[[Atrial fibrillation EKG examples|EKG Examples]] | |||
:[[Atrial fibrillation with LBBB EKG examples|A-Fib with LBBB]] | |||
|- | |- | ||
! | ! | ||
Line 131: | Line 139: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Atrial fibrillation other imaging findings|Holter Monitoring]] | [[Atrial fibrillation other imaging findings|Holter Monitoring and Exercise Stress Testing]] | ||
|- | |- | ||
! | ! | ||
Line 141: | Line 149: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="CadetBlue" | ||
! | ! | ||
Treatment | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |||
|- bgcolor=" | |||
! | ! | ||
[[Atrial fibrillation rate control|Rate and Rhythm Control]] | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
Cardioversion | Cardioversion | ||
:[[Atrial fibrillation cardioversion| | :[[Atrial fibrillation cardioversion#Overview|Overview]] | ||
:[[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]] | :[[Atrial fibrillation electrical cardioversion|Electrical Cardioversion]] | ||
:[[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]] | :[[Atrial fibrillation pharmacological cardioversion|Pharmacological Cardioversion]] | ||
Line 164: | Line 170: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation anticoagulation| | Anticoagulation | ||
:[[Atrial fibrillation anticoagulation#Overview|Overview]] | |||
: [[Warfarin]] | : [[Warfarin]] | ||
: [[Dabigatran|Converting from or to Warfarin]] | : [[Dabigatran#Converting from or to Warfarin|Converting from or to Warfarin]] | ||
: [[Dabigatran|Converting from or to Parenteral Anticoagulants]] | : [[Dabigatran#Converting from or to Parenteral Anticoagulants|Converting from or to Parenteral Anticoagulants]] | ||
: [[Dabigatran]] | : [[Dabigatran]] | ||
|- | |- | ||
Line 174: | Line 181: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation rate control| | [[Atrial fibrillation maintenance of rate control and sinus rhythm|Maintenance of Sinus Rhythm]] | ||
|- | |- | ||
! | ! | ||
Line 180: | Line 187: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation | Surgery | ||
: [[Atrial fibrillation catheter ablation|Catheter Ablation]] | |||
: [[AV nodal ablation|AV Nodal Ablation]] | |||
: [[Atrial fibrillation surgical ablation|Surgical Ablation]] | |||
: [[Atrial fibrillation cardiac surgery|Cardiac Surgery]] | |||
|- | |- | ||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[Atrial fibrillation specific patient groups|Specific Patient Groups]] | |||
|- | |||
! | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation primary prevention|Primary Prevention]] | |||
|- | |- | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
Line 196: | Line 211: | ||
[[Atrial fibrillation secondary prevention|Secondary Prevention]] | [[Atrial fibrillation secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | ! | ||
[[Atrial fibrillation supportive trial data|Supportive Trial Data]] | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Atrial fibrillation | [[Atrial fibrillation cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
[[Atrial fibrillation case study one|Case #1]] | |||
|- | |||
! | |||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " | ||
Line 284: | Line 317: | ||
|- bgcolor="LightYellow" | |- bgcolor="LightYellow" | ||
! | ! | ||
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | [http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}] | ||
|- | |||
! | ! | ||
Latest revision as of 16:01, 22 July 2021
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation On the Web | |